Serum soluble endoglin is associated with clinical and endoscopic disease activity in ulcerative colitis.

Wang T, Jiang Y, Chen C, Zhou Z, Gao C, Wang J, Pan Y

Open source

DOI
10.17305/bb.2026.14722
Published
2026 Sep 17
Container
Biomolecules & biomedicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17305/bb.2026.14722,
  title = {Serum soluble endoglin is associated with clinical and endoscopic disease activity in ulcerative colitis.},
  author = {Wang T and Jiang Y and Chen C and Zhou Z and Gao C and Wang J and Pan Y},
  year = {2026},
  journal = {Biomolecules \& biomedicine},
  doi = {10.17305/bb.2026.14722},
  url = {https://doi.org/10.17305/bb.2026.14722}
}

RIS

TY  - JOUR
TI  - Serum soluble endoglin is associated with clinical and endoscopic disease activity in ulcerative colitis.
AU  - Wang T
AU  - Jiang Y
AU  - Chen C
AU  - Zhou Z
AU  - Gao C
AU  - Wang J
AU  - Pan Y
PY  - 2026
JO  - Biomolecules & biomedicine
DO  - 10.17305/bb.2026.14722
UR  - https://doi.org/10.17305/bb.2026.14722
ER  - 

APA

T, W., Y, J., C, C., Z, Z., C, G., J, W., & Y, P. (2026). Serum soluble endoglin is associated with clinical and endoscopic disease activity in ulcerative colitis.. Biomolecules & biomedicine. https://doi.org/10.17305/bb.2026.14722

Source records